Vanguard Fiduciary Trust
LXRX icon

Vanguard Fiduciary Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
1,634,571
+302,287
+23% +$589K ﹤0.01% 2328
2026
Q1 		$2.08M Buy
+1,332,284
New +$1.94M ﹤0.01% 2549

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust's LXRX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Lexicon Pharmaceuticals (LXRX) stake by 23% in Q2 2026, buying an estimated $589K and bringing the position to 1,634,571 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Vanguard Fiduciary Trust first reported a position in LXRX in Q1 2026 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,634,571 shares of Lexicon Pharmaceuticals worth $3.92M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 302,287 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $589K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2328 holding.
  • Vanguard Fiduciary Trust first reported a position in Lexicon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.